NEW YORK (GenomeWeb News) – Rosetta Genomics today posted a net loss of $2.2 million, flat with last year’s third-quarter net loss, with no revenue reported for the three-month period ended Sept. 30.

 

The firm’s R&D expenses also were flat with the comparable period last year at $1.4 million.